The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models-Reference-Cited by-同舟云学术

The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models

Published:2011-08-24 Issue:1 Volume:131 Page:8-17
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Hatiboglu Mustafa Aziz,Kong Ling-Yuan,Wei Jun,Wang Yongtao,McEnery Kayla Anne,Fuller Gregory N.,Qiao Wei,Davies Michael A.,Priebe Waldemar,Heimberger Amy B.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma;Sampson;J Neurosurg,1998

2. Determinants of survival in patients with brain metastases from cutaneous melanoma;Staudt;Br J Cancer,2010

3. Oral metronomic cyclophosphamide in elderly with metastatic melanoma;Borne;Invest New Drugs,2010

4. Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery;Gunturu;J Clin Oncol,2010

5. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative;Ghiringhelli;Eur J Immunol,2004

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder Cancer Prevention: Potential Molecular Targets and Their Clinically Relevant Agents;Current Pharmacology Reports;2023-06-26

2. STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts;Molecular Therapy - Nucleic Acids;2023-06

3. A Novel Ageladine A Derivative Acts as a STAT3 Inhibitor and Exhibits Potential Antitumor Effects;International Journal of Molecular Sciences;2023-05-16

4. Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis;Frontiers in Cell and Developmental Biology;2023-04-26

5. Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition;International Journal of Molecular Sciences;2023-03-01